Search Results - "Rosen, PJ"

Testing Psychodynamic Psychotherapy Skills Among Psychiatric Residents: The Psychodynamic Psychotherapy Competency Test by Mullen, Linda S., Rieder, Ronald O., Glick, Robert A., Luber, Bruce, Rosen, Paul J.

“…OBJECTIVE: Training in psychodynamic psychotherapy remains a core requirement of psychiatric residency training programs, yet no standard measures of…”
Get full text

Treatment Motivation and Therapeutic Engagement in Prison-Based Substance Use Treatment by Rosen, Paul J., Hiller, Matthew L., Webster, J. Matthew, Staton, Michele, Leukefeld, Carl

“…Studies of community-based substance use treatment show that motivation for treatment is critical for clients becoming therapeutically engaged. Little…”
Get full text

Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus by Paquette, R L, Meshkinpour, A, Rosen, P J

“…Autoimmune myelofibrosis is an uncommon disorder in which patients present with anemia and thrombocytopenia in conjunction with limited clinical manifestations…”
Get full text

Oncogenic osteomalacia associated with prostate cancer by Reese, D M, Rosen, P J

Get more information

Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria by Paquette, Ronald L., Yoshimura, Ryan, Veiseh, Charles, Kunkel, Lori, Gajewski, James, Rosen, Peter J.

“…Seven patients with paroxysmal nocturnal haemoglobinuria (PNH) were treated with antithymocyte globulin (ATG). Each patient received ATG (20 mg/kg/d) for 8 d…”
Get full text

Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer by Amado, R. G., Rosen, L. S., Hecht, J. R., Lin, L.-S., Rosen, P. J.

“…Background 5-Fluorouracil (5-FU)-based regimens have not been shown to prolong survival or provide clinical benefit in patients with advanced pancreatic…”
Get full text

Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy by Rosen, P J, Mendoza, E F, Landaw, E M, Mondino, B, Graves, M C, McBride, J H, Turcillo, P, deKernion, J, Belldegrun, A

“…To confirm the previously reported high response rates and prolonged survival in hormone-refractory prostate cancer treated with suramin. Thirty-six eligible…”
Get more information

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia by Rosen, Peter J., Rankin, Cathryn, Head, David R., Boldt, David H., Luthardt, Frederick W., Norwood, Thomas, Pugh, Reginald P., Karanes, Chatchada, Appelbaum, Frederick R.

“…Purpose: The Southwest Oncology Group performed a Phase II study to investigate the effectiveness of an induction regimen of high dose cytosine arabinoside…”
Get full text

Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer by Leichman, C G, Leichman, L, Spears, C P, Rosen, P J, Jeffers, S, Groshen, S

“…Biochemical modulation of bolus fluorouracil (5-FU) by addition of leucovorin to the treatment regimen has increased response in patients with disseminated…”
Get more information

Bleeding problems in the cancer patient by Rosen, P J

“…Bleeding problems in the cancer patient may result from the effects of the tumor on hemostatic mechanisms or from the treatment of the tumor by cytotoxic and…”
Get more information

A phase II trial of irinotecan in hormone-refractory prostate cancer by REESE, D. M, TCHEKMEDYIAN, S, CHAPMAN, Y, PRAGER, D, ROSEN, P. J

“…Irinotecan is a DNA topoisomerase I inhibitor that has a wide spectrum of activity against human tumors in both preclinical and clinical studies. To evaluate…”
Get full text

A novel pro-apoptotic agent SDX-101 (R-etodolac) for the treatment of B-cell chronic lymphocytic leukemia (B-CLL) by Jenson, M, Engert, A, Goebeler, ME, Weissinger, F, Wilhelm, M, Osterborg, A, Knauf, W, Kimby, EK, Rosen, PJ, Poynton, C, Rummel, MJ, Hillmen, P, Oliff, I, Kennedy, B, Jullusson, G, Latven, L, Scranton, SA, Paradiso, LJ

Get full text

Should we bother subclassifying Hodgkin's disease? by Rosen, P J

Get more information

Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers by Leichman, C G, Leichman, L, Spears, C P, Rosen, P J, Muggia, F, Jeffers, S, Waugh, W

“…A clinical trial was designed to find the maximally tolerated dose of weekly leucovorin (LV) that could be combined with 4 weeks of protracted infusion (PI) of…”
Get full text

A phase II trial of CI-921 in advanced malignancies by SKLARIN, N. T, WIERNIK, P. H, JOLIVET, J, RUCKDESCHEL, J. C, ROBERT, N. J, VELEZ-GARCIA, E, BERGSAGEL, D. E, PANASCI, L. C, VAN DER MEWE, A. M, LONGUEVILLE, J. J, LEIBY, J, KOWAL, C. D, GROVE, W. R, BENSON, L, MITTELMAN, A, MAROUN, J. A, STEWART, J. A, ROBERT, F, DOROSHOW, J. H, ROSEN, P. J

“…CI-921, (9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]- N,5-dimethyl-4-acridinecarboxamide 2-hydroxyethanesulfonate (1:1)), an anilinoacridine…”
Get full text

Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity by Rosen, P J, Feinstein, D I, Pattengale, P K, Tindle, B H, Williams, A H, Cain, M J, Bonorris, J B, Parker, J W, Lukes, R J

“…Twelve adults had a distinct clinicopathologic type of malignant lymphoma that closely resembles the mediastinal lymphomas of childhood. Nine patients…”
Get more information

Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency by Rosen, P J, Johnson, C, McGehee, W G, Beutler, E

Get more information

Lymphocyte-depletion Hodgkin's disease. A clinicopathological entity by Neiman, R S, Rosen, P J, Lukes, R J

Get more information

Cancer Immunotherapy by Plotkin, David, Rosen, Peter J

“…To the Editor.—The discussion of BCG vaccine by Hersh et al (235:646, 1976) is appropriately subtitled "Potential, Practical Considerations, and Precautions in…”
Get full text

Acute lymphocytic leukemia manifesting as splenic rupture by Johnson, C S, Rosen, P J, Sheehan, W W

“…Pathologic rupture of the spleen is a rare phenomenon in acute lymphocytic leukemia, and its mechanism is unknown. This complication has been seen almost…”
Get more information